Squamous cell carcinoma staging
Pro Research Analysisby 
Searched over 200M research papers
Cutaneous Squamous Cell Carcinoma Staging Systems: AJCC, UICC, and BWH
Staging of cutaneous squamous cell carcinoma (cSCC) is essential for identifying high-risk patients, guiding treatment, and predicting outcomes. The most widely used systems are the American Joint Committee on Cancer (AJCC), the International Union Against Cancer (UICC), and the Brigham and Women's Hospital (BWH) staging systems. Each system uses tumor characteristics to stratify risk, but their effectiveness varies, especially in distinguishing high-risk cases 1234+3 MORE.
AJCC and UICC Staging: Features and Limitations
The AJCC and UICC systems have traditionally grouped nonmelanoma skin cancers together, but recent editions have created separate criteria for cSCC. The AJCC 7th and 8th editions use tumor diameter, depth of invasion, perineural invasion, differentiation, and bone involvement to assign T stages. However, studies show that these systems often fail to clearly distinguish between intermediate and high-risk tumors, with most poor outcomes occurring in lower stages (T1/T2), leading to heterogeneous risk groups 2345+2 MORE. The AJCC 8th edition, which focuses on head and neck cSCC, has improved distinctiveness and homogeneity compared to the 7th edition, but some overlap remains with the BWH system 56.
Brigham and Women's Hospital (BWH) Staging: Improved Risk Stratification
The BWH system incorporates four key risk factors: poor differentiation, perineural invasion, tumor diameter ≥2 cm, and invasion beyond subcutaneous fat. This system better identifies a small subset of high-risk tumors (T2b/T3), which account for the majority of nodal metastases and disease-specific deaths, while most low-stage tumors have excellent outcomes 245. Studies consistently show that the BWH system offers superior distinctiveness, homogeneity, and monotonicity compared to AJCC and UICC, making it more effective for identifying patients who need closer follow-up or aggressive treatment 245.
Staging for Non-Head and Neck and Oral SCC
For non-head and neck cSCC, both the AJCC 8th edition and BWH systems can predict poor outcomes, with high-stage tumors showing higher specificity for major poor outcomes . In oral squamous cell carcinoma (OSCC), the AJCC/UICC TNM 8th edition has incorporated depth of invasion and extranodal extension, improving risk stratification, though further refinements are suggested .
Clinical Application and Imaging in Staging
Current guidelines recommend using AJCC 8th edition, UICC 8th edition, or BWH systems for staging cSCC, with risk stratification into low- and high-risk groups based on tumor and patient factors . Physical examination, including lymph node palpation, is essential for all cSCCs. Imaging (ultrasound, MRI, CT, PET-CT) is recommended for staging high-risk cases, while sentinel lymph node biopsy is not routinely advised .
Conclusion
Staging of squamous cell carcinoma, especially cutaneous forms, is critical for prognosis and management. The BWH system provides improved risk stratification over AJCC and UICC, particularly for identifying high-risk tumors. The AJCC 8th edition has made significant advances, especially for head and neck cSCC, but some limitations remain. Accurate staging, combined with appropriate imaging and risk assessment, is key to optimizing patient outcomes 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic